Trial Profile
A Phase II Study of SPP-003 for Nephrotoxicity Induced by Cisplatin-based Chemotherapy
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 19 Dec 2022
Price :
$35
*
At a glance
- Drugs Aminolevulinic acid/sodium ferrous citrate (Primary)
- Indications Lung cancer
- Focus Therapeutic Use
- Sponsors SBI Pharmaceuticals Co Ltd
- 01 Jan 2022 Status has been changed to completed, as per Results published in the Oncology
- 25 Oct 2018 New trial record